| Timothy F Obermiller, MD | |
|
350 Heritage Way, Suite 2100, Kalispell, MT 59901-3158 | |
| (406) 257-8992 | |
| (406) 257-8996 |
| Full Name | Timothy F Obermiller |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 39 Years |
| Location | 350 Heritage Way, Kalispell, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720011927 | NPI | - | NPPES |
| 0072590 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 8103 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kalispell Regional Medical Center | Kalispell, MT | Hospital |
| North Valley Hospital | Whitefish, MT | Hospital |
| Cabinet Peaks Medical Center | Libby, MT | Hospital |
| St Luke Community Hospital | Ronan, MT | Hospital |
| Clark Fork Valley Hospital | Plains, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kalispell Regional Medical Center Inc | 5294644381 | 354 |
News Archive
Dartmouth researchers and their colleagues have carried out the first total syntheses of certain compounds involved in excessive cell death in leukemia.
The patented 96-well Multi-Tier Microplate System from Porvair Sciences and sister company - JG Finneran is a unique device providing analysts with the convenience of an ANSI/SLAS microplate footprint but loaded with inert glass vials.
The sensors have the same size and thickness as a fingernail and reduce the time needed to identify DNA chains to several minutes or a few hours, depending on each chain.
The U.S. Food and Drug Administration is reminding health care professionals and patients not to use drugs intended to be sterile that were produced by Medaus Inc., due to lack of sterility assurance. The FDA has issued a formal request to the Birmingham, Alabama, compounding pharmacy to recall all non-expired lots of drug products intended to be sterile.
› Verified 8 days ago
| Entity Name | Kalispell Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
Dartmouth researchers and their colleagues have carried out the first total syntheses of certain compounds involved in excessive cell death in leukemia.
The patented 96-well Multi-Tier Microplate System from Porvair Sciences and sister company - JG Finneran is a unique device providing analysts with the convenience of an ANSI/SLAS microplate footprint but loaded with inert glass vials.
The sensors have the same size and thickness as a fingernail and reduce the time needed to identify DNA chains to several minutes or a few hours, depending on each chain.
The U.S. Food and Drug Administration is reminding health care professionals and patients not to use drugs intended to be sterile that were produced by Medaus Inc., due to lack of sterility assurance. The FDA has issued a formal request to the Birmingham, Alabama, compounding pharmacy to recall all non-expired lots of drug products intended to be sterile.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy F Obermiller, MD 350 Heritage Way, Suite 2100, Kalispell, MT 59901-3158 Ph: (406) 257-8992 | Timothy F Obermiller, MD 350 Heritage Way, Suite 2100, Kalispell, MT 59901-3158 Ph: (406) 257-8992 |
News Archive
Dartmouth researchers and their colleagues have carried out the first total syntheses of certain compounds involved in excessive cell death in leukemia.
The patented 96-well Multi-Tier Microplate System from Porvair Sciences and sister company - JG Finneran is a unique device providing analysts with the convenience of an ANSI/SLAS microplate footprint but loaded with inert glass vials.
The sensors have the same size and thickness as a fingernail and reduce the time needed to identify DNA chains to several minutes or a few hours, depending on each chain.
The U.S. Food and Drug Administration is reminding health care professionals and patients not to use drugs intended to be sterile that were produced by Medaus Inc., due to lack of sterility assurance. The FDA has issued a formal request to the Birmingham, Alabama, compounding pharmacy to recall all non-expired lots of drug products intended to be sterile.
› Verified 8 days ago
Dr. Tobin James Hoppes, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 75 Claremont St Ste H, Kalispell, MT 59901 Phone: 406-752-7406 Fax: 406-752-7544 | |
Marise K Johnson, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1280 Burns Way, Kalispell, MT 59901 Phone: 406-755-5266 Fax: 406-755-0228 | |
Kerry J Eby, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-6725 | |
Dr. Jeffrey W. Watkins, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 350 Heritage Way Ste 2100, Kalispell, MT 59901 Phone: 406-257-8992 Fax: 406-275-8996 | |
Torbjorn Ingvar Joreteg, MD PHD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 160 Heritage Way, Kalispell, MT 59901 Phone: 406-755-7785 Fax: 406-755-7857 | |
Nathaniel Lyle Hall, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, Suite 2100, Kalispell, MT 59901 Phone: 406-257-8992 Fax: 406-751-4161 | |
Anna Rose Robbins, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 310 Sunnyview Ln, Northwest Hospitalists, Kalispell, MT 59901 Phone: 406-751-5310 Fax: 406-751-5769 |